West Announces Three New Product Innovations at Pharmapack Europe

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) announced its participation at Pharmapack Europe 2023, showcasing innovations in injectable drug packaging. The company introduced three new products: West Ready Pack™ with Corning Valor® RTU Vials, Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System, and FluroTec® 5-10mL Cartridge Plunger. These innovations aim to address the demands of complex drug delivery and enhance patient safety. Additionally, West's presentations include discussions on market trends and innovations in drug delivery systems, highlighting the company's ongoing commitment to improving patient adherence and pharmaceutical solutions.

Positive

• Introduction of three new product innovations that enhance drug delivery solutions.
• Participation in Pharmapack Europe demonstrates commitment to addressing industry challenges.
• Expected growth in the demand for injectable drugs aligns with product introductions.

Negative

• None.

Product introductions and expert presentations offer thought leadership in drug delivery innovation and patient adherence to meet the challenges of pharmaceutical pipelines

EXTON, Pa., Jan. 31, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced participation at Pharmapack Europe 2023 in Paris, France to showcase its leadership and expertise on industry challenges and trends in packaging and containment. The company expands its innovations for global customers and their patients with the introduction of three new products: West Ready Pack™ with Corning Valor® RTU Vials utilizing Stevanato Group's EZ-fill® SG EZ-fill® technology, Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System and FluroTec® 5-10mL Cartridge Plunger.

"This year, we are introducing three new product solutions at Pharmapack," said Li Chen, Vice President and General Manager, Biologics at West. "With these innovations, we are addressing the growing market needs for today's complex and sensitive molecules, including large-volume delivery and a complete vial containment solution that can protect and scale from development through commercialization."

West's participation in this year's conference includes:

• Learning Lab: How Market Trends Drive Innovation and Enable the Pharmaceutical Pipeline
• Dr. Nico Brandes, Director, Polymer Prefilled Systems and Vial Containment
• Wednesday, February 1, 2023, 12:50 – 13:20 pm CET
• Panel Session: Innovation of Novel Medicines and Trends in Demand for Injectable Home and Self-Administration
• Gurmeet Singh, Senior Director, Business Development
• Wednesday, February 1, 2023, 14:40 – 15:30 pm CET
• Innovation Tours:
• West Ready Pack™ with Corning Valor® RTU Vials utilizing Stevanato Group's EZ-fill®  Technology
• Speaker: Doug Cusato, Senior Director, Glass Systems
• Wednesday, February 1, 2023, 10:17 – 10:22 am CET
• Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System
• Speaker: Victoria Morgan, Director, Global Biologics
• Thursday, February 2, 2023, 13:24 - 13:29 pm CET

For more information about West, please visit our website: www.westpharma.com

For more information about  Pharmapack , please visit: Pharmapack Europe

About West 
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With approximately 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 45 billion components and devices each year.  

2023 marks West's 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2021 generated $2.83 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

© 2023 West Pharmaceutical Services, Inc.

Ready Pack, Flip-Off, NovaPure, and FluroTec are trademarks or registered trademarks of West Pharmaceutical Services, Inc. in the United States and other jurisdictions.

FluroTec technology is licensed from Daikyo Seiko, Ltd.

Valor® is a registered trademark of Corning Incorporated.

EZ-fill is a registered trademark of Stevanato Group.

West Pharmaceutical Services, Inc. is the exclusive distributor of Corning Valor® Glass.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-three-new-product-innovations-at-pharmapack-europe-301734160.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

What new products did West Pharmaceutical announce on January 31, 2023?

West Pharmaceutical announced the introduction of West Ready Pack™ with Corning Valor® RTU Vials, Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System, and FluroTec® 5-10mL Cartridge Plunger.

When and where did West participate in Pharmapack Europe?

West participated in Pharmapack Europe on February 1-2, 2023, in Paris, France.

What is the significance of West's innovations for the pharmaceutical industry?

West's innovations address the growing market needs for complex drug delivery and ensure safe containment for sensitive molecules.

How does West's participation in Pharmapack benefit its market position?

Participation in Pharmapack strengthens West's market position by showcasing its leadership and commitment to innovation in drug delivery solutions.